Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_36664
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 36664
Character Range: 1876035–1877256

36664                         Both:                                                                                                                                                                                                                                                                                                                                                                                                                                                                           617.60
                              (a) percutaneous repositioning of sacral nerve lead or leads using fluoroscopic guidance, or open repositioning of sacral nerve lead or leads; and
                              (b) intra‑operative test stimulation, to correct displacement or unsatisfactory positioning, if inserted for the management of:
                              (i) detrusor over‑activity that has been refractory to at least 12 months conservative non‑surgical treatment; or
                              (ii) non‑obstructive urinary retention that has been refractory to at least 12 months conservative non‑surgical treatment;
                              other than a service to which item 36663 applies (Anaes.)